Edition:
United States

Protagonist Therapeutics Inc (PTGX.OQ)

PTGX.OQ on NASDAQ Stock Exchange Global Market

18.23USD
14 Dec 2017
Change (% chg)

$0.07 (+0.39%)
Prev Close
$18.16
Open
$18.30
Day's High
$18.67
Day's Low
$18.11
Volume
29,255
Avg. Vol
35,973
52-wk High
$23.35
52-wk Low
$8.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 8.78 -0.285
Jun '17 0.00 -0.888
Mar '17 0.00 -0.841
FY 2016 Dec '16 0.00 -0.767
Sep '16 0.00 -0.503
Jun '16 0.00 -0.500
Mar '16 0.00 -0.804
FY 2015 Dec '15 0.00 -0.377
Sep '15 0.00 -0.238
Jun '15 0.00 -0.220
Mar '15 0.00 -0.184
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 8.76 9.50 8.00 --
Year Ending Dec-17 4 18.47 21.76 16.80 0.00
Year Ending Dec-18 4 36.78 62.44 20.00 66.67
Earnings (per share)
Quarter Ending Dec-17 3 -0.38 -0.33 -0.42 -0.54
Year Ending Dec-17 4 -2.29 -2.05 -2.39 -2.23
Year Ending Dec-18 4 -1.48 -0.33 -2.03 0.19
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 190.77 35.50
P/E High - Last 5 Yrs. -- 277.36 45.22
P/E Low - Last 5 Yrs. -- 92.80 24.21
Beta -- 0.82 0.91
Price to Sales (TTM) 42.41 117.72 5.89
Price to Book (MRQ) 5.34 21.83 5.66
Price to Tangible Book (MRQ) 6.44 25.81 7.25
Price to Cash Flow (TTM) -- 103.69 24.38
% Owned Institutions 73.45 5.72 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.00 5.25
Payout Ratio(TTM) -- 98.06 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -3.06 6.81
Sales (TTM) vs TTM 1 Yr. Ago -- 30.14 5.59
Sales - 5 Yr. Growth Rate -- 33.20 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 43.31 -148.11 7.98
EPS (TTM) vs TTM 1 Yr. Ago -27.33 -- --
EPS - 5 Yr. Growth Rate -- 43.94 10.93
Capital Spending - 5 Yr. Growth Rate -- 41.00 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) 1.87 5.70 3.57
LT Debt to Equity (MRQ) 0.00 14.63 13.37
Total Debt to Equity (MRQ) 0.00 17.10 19.35
Interest Coverage (TTM) -5.13 -135.87 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.20 54.91
Gross Margin - 5 Yr. Avg. -- 55.70 52.46
EBITD Margin (TTM) -517.22 -- --
EBITD - 5 Yr. Avg -- -219.33 15.51
Operating Margin (TTM) -521.36 -637.28 6.68
Operating Margin - 5 Yr. Avg. -- -236.27 10.99
Pre-Tax Margin (TTM) -514.21 -607.21 7.52
Pre-Tax Margin - 5 Yr. Avg. -- -236.41 11.40
Net Profit Margin (TTM) -514.21 -604.71 3.74
Net Profit Margin - 5 Yr. Avg. -- -239.71 7.69
Effective Tax Rate (TTM) -- 15.46 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 250,886 21,870,754 851,754,569
Net Income/Employee (TTM) -1,290,086 -1,731,043 99,535,212
Receivable Turnover (TTM) 5.24 26.18 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.08 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -42.35 -9.33 11.32
Return on Assets - 5 Yr. Avg. -- 0.11 12.28
Return on Investment (TTM) -58.01 -11.61 14.44
Return on Investment - 5 Yr. Avg. -- 3.32 16.08
Return on Equity (TTM) -58.14 -35.87 16.05
Return on Equity - 5 Yr. Avg. -- 5.69 17.28
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -152.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Protagonist Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 73.45%
# of Holders: 74
Total Shares Held: 15,005,950
3 Mo. Net Change: 5,709
# New Positions: 9
# Closed Positions: 10
# Increased Positions: 33
# Reduced Positions: 23
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.